Prostatic acid phosphatase antigens

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 9/16 (2006.01) A61K 39/385 (2006.01) A61K 48/00 (2006.01) A61P 35/00 (2006.01) C07K 16/40 (2006.01) C12N 5/10 (2006.01) C12N 15/55 (2006.01) C12N 15/63 (2006.01) C12Q 1/68 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2559840

The invention relates to peptides from Prostatic Acid Phosphatase (PAP), especially those identified as PAP.135 and PAP.161. The nucleic acid molecules encoding the peptides, antibodies against the peptides, and the use of such peptides, nucleic acids and antibodies in immunotherapy, vaccines and assays are also included in the scope of the invention.

Cette invention se rapporte à des peptides tirés de l'acide prostatique phosphatase (PAP), en particulier ceux identifiés sous l'appellation PAP.135 et PAP.161. Les molécules d'acides nucléiques codant ces peptides, des anticorps contre ces peptides et l'utilisation de ces peptides, acides nucléiques et anticorps en immunothérapie, vaccins et dosages sont également couverts par cette invention.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Prostatic acid phosphatase antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prostatic acid phosphatase antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostatic acid phosphatase antigens will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1892194

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.